Tech Company Financing Transactions

ViaCyte Funding Round

On 5/24/2017, ViaCyte received $10 million in funding from Asset Management Ventures, JDRF T1D Fund and W.L. Gore & Associates.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
This capital will be used to fund the initiation of clinical development for ViaCyte's PEC-Direct product candidate, which holds the promise of becoming a functional cure for type 1 diabetes patients at high risk for acute complications.

Company Information

Company Status
Private & Independent
Mailing Address
3550 General Atomics Ct.
San Diego, CA 92121
Email Address
ViaCyte is a preclinical therapeutic company focused on diabetes. Our therapy is based on pancreatic beta cell progenitors (Pro-Islet) derived from human pluripotent stem cells. These cells are implanted using a durable and retrievable encapsulation device.
ViaCyte LinkedIn Company Profile
Social Media
ViaCyte Company Twitter Account
Company News
ViaCyte News
ViaCyte on Facebook
ViaCyte on YouTube

Management Team

Email & Social
Chief Executive Officer
Michael Yang
  Michael Yang LinkedIn Profile  Michael Yang Twitter Account  Michael Yang News  Michael Yang on Facebook
Chief Financial Officer
Brittany Bradrick
  Brittany Bradrick LinkedIn Profile  Brittany Bradrick Twitter Account  Brittany Bradrick News  Brittany Bradrick on Facebook
Chief Medical Officer
Howard Foyt
  Howard Foyt LinkedIn Profile  Howard Foyt Twitter Account  Howard Foyt News  Howard Foyt on Facebook
Chief Scientific Officer
Kevin D'Amour
  Kevin D'Amour LinkedIn Profile  Kevin D'Amour Twitter Account  Kevin D'Amour News  Kevin D'Amour on Facebook
Chief Technical Officer
Steve White
  Steve White LinkedIn Profile  Steve White Twitter Account  Steve White News  Steve White on Facebook
Vice President
Manasi Jaiman
  Manasi Jaiman LinkedIn Profile  Manasi Jaiman Twitter Account  Manasi Jaiman News  Manasi Jaiman on Facebook
VP - Finance
Anne Sandan
  Anne Sandan LinkedIn Profile  Anne Sandan Twitter Account  Anne Sandan News  Anne Sandan on Facebook
VP - General Counsel
Liz Bui
  Liz Bui LinkedIn Profile  Liz Bui Twitter Account  Liz Bui News  Liz Bui on Facebook
VP - Regulatory Affairs
Steve Kradjian
  Steve Kradjian LinkedIn Profile  Steve Kradjian Twitter Account  Steve Kradjian News  Steve Kradjian on Facebook



Browse more venture capital transactions:

Prev: 5/23/2017: LumaStream venture capital transaction
Next: 5/24/2017: Minibrew venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary